SLNO Research and Charts

SLNO - Soleno Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 83.78	Change ⇑ +0.53 (+0.64%)	Volume 1,418,235
	Open 83.33	High 86.79	Low 83.13

8EMA (Daily) 82.70	40EMA (Daily) 77.06	50EMA (Daily) 75.43	STO (Daily) 80.051	MACD Hist (Daily) 0.524
8EMA (Weekly) 78.681	40EMA (Weekly) 62.43	50EMA (Weekly) 59.31	STO (Weekly) 91.165	MACD Hist (Weekly) 1.806


Company Profile
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.